Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-020860
Filing Date
2025-02-14
Accepted
2025-02-14 13:21:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10191
2 EX-99.1 ck0001669811-ex99_1.pdf EX-99.1 256568
  Complete submission text file 0000950170-25-020860.txt   365627
Mailing Address 11555 SORRENTO VALLEY ROAD, SUITE 203 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD, SUITE 203 SAN DIEGO CA 92121 619-941-0360
AETHLON MEDICAL INC (Subject) CIK: 0000882291 (see all company filings)

EIN.: 133632859 | State of Incorp.: NV | Fiscal Year End: 0331
Type: SCHEDULE 13G | Act: 34 | File No.: 005-61769 | Film No.: 25626142
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201
Business Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201 214-364-2883
Ikarian Capital, LLC (Filed by) CIK: 0001778253 (see all company filings)

EIN.: 473466768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G